BTIG initiated coverage of Amplitude (AMPL) with a Buy rating and $14 price target The firm sees GenAI accentuating the “better together” platform story for Amplitude and sees agents helping bridge gaps and bottlenecks between product analytic workflows. While growth has rebounded, BTIG sees improved execution, a healthier installed base, and an attractive GenAI strategy driving continued strength in growth durability over the medium term, the analyst tells investors in a research note.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMPL:
